GSK forecast sales in 2025 to grow 3%-5% and reported better-than-expected fourth-quarter earnings, as strength in its HIV and oncology portfolio offset weakness in its vaccines division.

Snapchat (SNAP) reported its Q4 2024 earnings results today, posting beats on both earnings per share (EPS) and revenue expectations.

Idexx Laboratories exceeded earnings expectations for Q4 2024, buoyed by robust performance in its key diagnostic segments.

Olin Corporation OLN reported fourth-quarter 2024 net income of $10.7 million or 9 cents per share, a decline from the prior-year quarter’s profits of $52.9 million or 43 cents. Earnings beat the Zacks Consensus Estimate of a loss of a penny per share.